期刊文献+

IL-27对支气管哮喘患者血清干扰素γ、IL-33水平的影响 被引量:5

Interleukin-27 affects serum IFN-gumma and IL-33 activities in patients with bronchial asthma
原文传递
导出
摘要 目的探讨1L-27对支气管哮喘(简称哮喘)患者干扰素y(lFN-γ)及1L-33的调节作用。方法选择56例非细菌性感染所致中-重度哮喘患者为试验病例组,整群匹配方法选择30名正常者为对照组,酶联免疫吸附试验法检测1L-27、干扰素y(IFN-y)、1L-33水平,全血细胞分析仪检测白细胞数、中性校细胞绝对值、嗜酸粒细胞绝对值;同时收集哮喘组患者外周血单个核细胞(PBMC).加入不同浓度的(5μgiL或0.5μgiL)重组人白介素27(rh1L-27)进行体外培养12 h.酶联免疫吸附试验法检测其培养 上清1FN-y及1L-33浓度;探讨1L-27对1FN-γ、1L-33的影响及各指标间的相关性。结果哮喘组患者血清1L-33较对照组明显升高(t=34. 53. P 〈0. 05).哮喘组1FN-γ、1L-27水平较对照组明显降低 ( t IFN-γ=27.52. P IFNγ〈0.01; t IL-27 = 32.77 ? P IL-27 〈0.01) ;不同浓度的rh1L-27刺激PBMC后进行体 外培养后.IFN-y表达分别为[(85.9±12. 1)μgiL.(19.6± 3.2)μgl日,较细胞剌激素组(11. 3±2. 7)μgiL 均有显著升高(t = 34.57. P 〈0. 01; t = 11. 39. P 〈0. OIL 5μgiL rh 1L-27组1L-33表达较对照组有 明显降低[(33.2士11.8)μgiL vs 016.9土17.的μgiL. t =22.69. P 〈0. 01];哮喘患者1FNγ水平变 化与rh1L-27应用剂量呈正相关性( r = 0. 949. P 〈 0. 0日,而rh 1L-27与1L-33呈负相关性(r = 0.89. P 〈0. 05)。结论 1L-27、1FN-y、1L-33表达水平间存在一定关联强度。 Objective To study the effect of interleukin (IL)-27 on INF-y and IL-33 activities in patients with bronchial asthma (asthma). Methods Two groups of experiments, the serum levels of IFN-y and IL-27 and IL-33 in asthmatic patients or control group by ELISA. The levels of WBC and neutrophils and EOS by hematology analyzer. PBMCs from 33 asthmatic patients were cultured with recombinant human IL-27 (5 μg/L or 0. 5 μg/L) for 12 hours in vitro, and then the levels of IFN-y and IL-33 in their supernatant were measured by ELISA. The explore of correlation between IL-27 activating factor and IL-33 , IFN-y in the asthmatic patients. Results The levels of IL-33 in asthmatic patients were significantly increased and IFN-y, IL-27 had a significant decrease compared with that in healthy control group (t IFN-y=27. 52, P IFN-y〈0. 01; t IL-27 =32.77, P IL-27 〈0. 01). The values of IFN-y in supernatant were (85.9 ± 12.1) flg/L, (19. 6 ± 3.2) μg/L compared with that in cytokine stimulated control group (11. 3±2. 7) μg/L had increased significantly ( t = 34.57, P 〈0. 01; t = 11. 39, P 〈0. 01). The group treated with 5 μg/L IL-27 had decreased significantly IL-33 levels compared with the cytokine stimulated control group [(33. 2± 11. 8) μg/L vs (116. 9± 17.6) μg/L, t = 22. 69, P 〈0.01]. There was a positive correlation between IFN-y and IL-27 in asthmatic patients. Conclusions The levels of IL-27 ,IFN-y, IL-33 were interelated.
出处 《国际呼吸杂志》 2014年第5期321-324,共4页 International Journal of Respiration
基金 2013年湖北省自然科学基金指导性项目(2013CFC057) 黄石市医药卫生科研项目(2013-34)
关键词 支气管哮喘 白介素27 白介素33 Bronchial asthma Interleukin-27 Interleukin-33
  • 相关文献

参考文献3

二级参考文献21

  • 1中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断及防治指南.中华儿科杂志,2009,42(1):1-3.
  • 2Lourenco O, Mafalda Fonseca A, Taborda-Barata L. T cells in sputum of asthmatic patients are activated independently of disease severity or control [ J ]. Allergol hnmunopathol, 2009, 37 (6) :285-292.
  • 3Nakanishi K, Tsutsui H, Yoshimoto T. Importance of IL/-18-induced super Th1 cells for the development of allergic inflammation [J]. Allergollnt, 2010, 59(2): 137-141.
  • 4Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EB I3 and p28 protein, induces proliferation of naive CD4^+ T cells[ J]. Immunity, 2002, 16 (6) :779-790.
  • 5Batten M, Li J, Kljavin NM, Danilenko DM, Lucas S, Lee J, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. [J]. Nat Immunol, 2006, 7(9) :929-936.
  • 6Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system [ J ]. Nat Immunol, 2006, 7(9) :937-945.
  • 7Yoshimoto T, Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells : a novel therapeutic way for Th2-mediated allergic inflammation[ J]. J Immunol, 2007, 179 (7) : 4415-4423.
  • 8中华医学会耳鼻咽喉科学分会 中华耳鼻咽喉科杂志编辑委员会.变应性鼻炎诊断标准及疗效评定标准.中华儿鼻咽喉科杂志,1998,.
  • 9Knisz J,Rothman PB.Suppressor of cytokine signaling in allergicInflammation[J].J Allergy Clin Immunol,2007,119(3):739-745.
  • 10Egwuagu CE,Yu CR,Zhang M,Mahdi RM,Kim SJ,Gery I.Suppressors of cytokine signaling proteins are differentially ex-pressed in Th1 and Th2 cells:implications for Th cell lineage com-mitment and maintenance[J].J Immunol[J].2002,168(7):3181-3187.

共引文献40

同被引文献52

  • 1Pflanz S,Timans JC, Cheung J ,et al. IL-27 , a heterodimeric cyto-kine composed of EBI3 and p28 protein,induces proliferation ofnaive CD4 + T cells [ J ]. Immunity,2002,16(6) :779-790.
  • 2Pflanz S,Hibbert L,Mattson J,et al. WSX-1 and glycoprotein 130constitute a signal-transducing receptor for IL-27 [ J ]. J Immunol,2004,172(4) :2225-2231.
  • 3Vignali DA, Kuchroo VK. IL-12 family cytokines: immunologicalplaymakers[ J]. Nat Immunol ,2012 ,13(8) :722-728.
  • 4Tormo AJ, Meliani Y, Beaupr6 LA, et al. The composite cytokinep28/cytokine>like factor 1 sustains B cell proliferation and pro-motes plasma cell differentiation [ J]. J Immunol ,2013,191(4):1657-1665.
  • 5Forrester MA,Robertson L,Bayoumi N,et al. Human interleukin-27 :wide individual variation in plasma levels and complex inter-relationships with interleukin-17 A [ J ]. Clin Exp Immunol, 2014,178(2) :373-383.
  • 6Diegelmann J,Olszak T,Goke B,et al. A novel role for interleukin-27 (IL-27 ) as mediator of intestinal epithelial barrier protectionmediated via differential signal transducer and activator of tran-scription (STAT) protein signaling and induction of antibacterialand anti-inflammatory proteins[ J]. J Biol Chem,2012,287 (1 ):286-298.
  • 7Vroman H ,van den Blink B1 ,Kool M. Mode of dendritic cell acti-vation :The decisive hand in Th2/Thl7 cell differentiation. Impli-cations in asthma severity. [ J ] . Immunobiology ,2014,220 ( 2 ):254-261.
  • 8Owaki T,Asakawa M,Morishima N,ef al. A role for IL-27 in earlyregulation of Thl differentiation [ J]. J Immunol,2005,175 (4 ):2191-2200.
  • 9Takeda A, Hamano S, Yamanaka A, et al. Cutting edge: Role ofIL-27/WSX-1 signaling for induction of T-bet through activation ofSTAT1 during initial Thl commitment [ J ]. J Immunol, 2003,170.10) :48864890.
  • 10Villegas-Mendez A,de Souza JB,Lavelle SW,ef al. IL-27 receptorsignalling restricts the formation of pathogenic,terminally differen-tiated Thl cells during malaria infection by repressing IL-12dependent signals[ J]. PLoS Pathog,2013 ,9(4) :el003293.

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部